From: Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
Variables | Unadjusted standardized beta | P | R square | Adjusted standardized beta | P |
---|---|---|---|---|---|
Patients with MMSE sum score ≥ 25, N = 134 | |||||
Diagnoses (AD/aMCI = 2, others = 1) | 0.44 | <0.001 | 0.19 | 0.36 | <0.001 |
Age | 0.12 | 0.16 | 0.007 | ||
Sex (1 = women, 2 = men) | −0.17 | 0.05 | 0.02 | ||
ApoE ε4 genotype (neg = 1, pos = 2) | 0.26 | 0.002 | 0.06 | 0.2 | 0.008 |
Amyloid β | −0.36 | <0.001 | 0.12 | ||
MMSE | −0.39 | <0.001 | 0.15 | −0.31 | 0.001 |
R square | 0.32 | ||||
Patients with MMSE sum score < 25, N = 119 | |||||
Age | 0.07 | 0.46 | −0.004 | ||
Sex (1 = women, 2 = men) | −0.02 | 0.87 | −0.008 | ||
ApoE ε4 genotype (neg = 1, pos = 2) | 0.18 | 0.05 | 0.03 | ||
Amyloid β | −0.25 | 0.005 | 0.06 | −0.24 | 0.01 |
MMSE | −0.16 | 0.09 | 0.02 | ||
R square | 0.07 |